HomeNews

News

Drug Development

Gamaleya Center starts testing its anti-COVID medicine based on monoclonal antibodies

Pharma -
Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is launching trials of its new anti-COVID medicine based on monoclonal antibodies, the center’s chief...
Drug Development

Gamaleya Center can develop COVID-19 vaccine based on several strains

Pharma -
Deputy director of the center Denis Logunov specified that a part of the vaccine based on the Wuhan or Delta strain will be able...
Global Markets

WHO recommends two new drugs to treat patients with COVID-19

Pharma -
The World Health Organization (WHO) reccommended two new drugs to treat patients with COVID-19, one for patients with critical disease, and another deemed effective...
Global Markets

U.S. judge bars Martin Shkreli from the pharmaceutical industry, orders $64.6 mln payment

Pharma -
A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay $64.6 million after he famously...
Global Markets

South Korea to spend $5.3 billion for corporate investment in vaccine development

Pharma -
Finance Minister Hong Nam-ki said Thursday the government plans to spend 6.3 trillion won (US$5.3 billion) to support corporate facility investment in vaccine development...
Expert Opinion

WHO Interim Statement on composition of current and future COVID-19 vaccines

Pharma -
Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19...
1...737475...119Page 74 of 119
spot_img

Expert Articles

spot_img